Canaccord Genuity Initiates Coverage on Compass Therapeutics with Buy Rating and $10 PT

miércoles, 3 de diciembre de 2025, 7:47 am ET1 min de lectura
CMPX--

Canaccord Genuity Initiates Coverage on Compass Therapeutics with Buy Rating and $10 PT

Canaccord Genuity Initiates Coverage on Compass Therapeutics with Buy Rating and $10 PT

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios